Compass Therapeutics (NASDAQ:CMPX) executives highlighted what CEO and Vice Chair Dr. Thomas Schuetz called “absolutely ...

BJP's Palash Rana leads Bengal Phase 2 elections with ₹104 crore in assets, highlighting wealth disparities among candidates.

FDA accepted an RTOR sBLA and granted priority review for zanidatamab-hrii combinations as first-line therapy in HER2+ ...

By Michael Krallmann, CEO, TransLegal. For the legal tech community, cross-jurisdictional meaning raises questions of risk, liability and trust. Increasingly capable models, wrapped in ...

Clio has made a new move in the Big Law legal space with the launch of a new tool within its Vincent AI capability that ...

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

This bundle pairs Microsoft Office 2024 with a full training suite so you’re not just opening apps — you’re actually using ...

Bristol-Myers Squibb's growth portfolio nears 60% of total revenues, growing 16% YoY, effectively offsetting patent cliff ...

Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus paclitaxel alone in the key secondary endpoint of ...

These cities stand out in 2026 for low crime rates, affordable housing and reasonable living costs for retirees.

The data confirms what has been said repeatedly: these deaths are not isolated events, and are not beyond the control of the sheriff's office.